The Boston Scientific Eluvia self-expanding, drug-eluting, peripheral stent.
Feature | Stents | Saloni Walimbe

Cardiovascular diseases (CVDs) are among the leading causes of death across the globe. For patients suffering from high ...

Home February 11, 2020
Home
Feature | Artificial Intelligence | Sanjay Parekh, Ph.D. 

February 7, 2020 – At the 2019 Radiological Society of North America (RSNA) meeting in December, there was a record ...

Home February 11, 2020
Home
News | Interventional Radiology

February 11, 2020 — An ahead-of-print article in the April issue of the American Journal of Roentgenology (AJR) ...

Home February 11, 2020
Home
Videos | Heart Failure

Interview with James Udelson, M.D., chief of the division of cardiology at Tufts Medical Center, Boston. The hospital ...

Home February 10, 2020
Home
News | Hypertension

February 7, 2020 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the Aria ...

Home February 07, 2020
Home
Videos | Hemodynamic Support Devices

Interview with Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and Innovation (CVCRI), director, Acute Mechanical Circulatory Support Program; director, interventional research laboratories; director of Cardiac Biology Research Center, Molecular Cardiology Research Institute (MCRI), Tufts Medical Center. He explains the Door-to-Unloading (DTU) Trial...

Home February 07, 2020
Home
News | Interventional Radiology

February 4, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the Society ...

Home February 04, 2020
Home
News | Left Atrial Appendage (LAA) Occluders

February 3, 2020 — The U.S. Food and Drug Administration (FDA) has approved a the CATALYST trial designed to assess ...

Home February 03, 2020
Home
News | Dave Fornell, Editor

February 3, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home February 03, 2020
Home
News | Heart Valve Technology

January 31, 2020 — A new study from the Smidt Heart Institute at Cedars-Sinai and other centers nationwide shows that ...

Home January 31, 2020
Home
News | Atrial Fibrillation

January 31, 2020 – The U.S. Food and Drug Administration (FDA) has given Medtronic approval to proceed with an ...

Home January 31, 2020
Home
News | Cath Lab

January 29, 2020 – Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician ...

Home January 31, 2020
Home
News | Endovascular Aortic Repair

January 31, 2020 – The Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) released new reporting ...

Home January 31, 2020
Home
Abbott Tendyne TMVR, TMVI system received European CE mark clearance in January 2020. The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system uses an anchor attached to the apex of the heart with a whether line attached to the valve. This helps to keep the valve anchored in the mitral annulus and prevent embolization. This anchor system was used because, unlike the aortic valve, the mitral valve has a very thin landing zone to secure the valve. Prevents LVOT obstruction.
Feature | Heart Valve Technology

January 30, 2020 — The Abbott Tendyne Transcatheter Mitral Valve Implantation (TMVI) system received European CE mark ...

Home January 30, 2020
Home
Subscribe Now